Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response
J. Borawski et al., Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response, NEPH DIAL T, 16(7), 2001, pp. 1442-1447
Background, Increased plasma soluble von Willebrand factor antigen (VWF:Ag)
level, a marker of vascular endothelial cell dysfunction, is a strong pred
ictor of atherosclerotic cardiovascular disease (CVD) in the general popula
tion. We studied cross-sectional associations between vWF:Ag level, prevale
nce of CVD, and related factors including pre-dialysis arterial blood press
ure (BP) and some markers of inflammation in maintenance haemodialysis (HD)
patients.
Methods and results. Plasma vWF:Ag level measured by an enzyme-linked immun
osorbent assay (ELISA) was higher in 110 HD patients than in 20 controls. O
n bivariate regression analysis, vWF:Ag level was directly associated with
the presence of CVD, age, fibrinogen and the use of enoxaparin (vs unfracti
onated heparin) during HD procedures, and inversely with albumin and pre-di
alysis BP. The patients with prevalent CVD were older, had higher vWF:Ag, w
hite blood cell and platelet counts, fibrinogen and triglycerides, lower al
bumin levels, and were less frequently on combination antihypertensive ther
apy. Multivariable analyses identified low pre-dialysis BP. hypoalbuminaemi
a and hyperfibrinogenaemia (in descending order of significance) as indepen
dent predictors of high vWF:Ag level. There were no associations between VW
F : Ag levels and gender. ABO blood type, smoking, body mass index. renal f
ailure cause, duration of HD therapy, K-t/V, normalized protein catabolic r
ate, dialysate buffers, dialysers, viral hepatitis, erythropoietin treatmen
t, specific antihypertensive drugs, haemoglobin, white blood cell and plate
let counts, liver enzymes. phosphorous, total cholesterol, and triglyceride
s.
Conclusion. Elevated plasma levels of endothelial dysfunction marker vWF:Ag
in maintenance HD patients are associated with established cardiovascular
mortality risk factors such as low pre-dialysis blood pressure and the acti
vated acute phase response.